AU1896195A - Recombinant adenoviruses coding for acidic fibroblast growth factor (afgf) - Google Patents
Recombinant adenoviruses coding for acidic fibroblast growth factor (afgf)Info
- Publication number
- AU1896195A AU1896195A AU18961/95A AU1896195A AU1896195A AU 1896195 A AU1896195 A AU 1896195A AU 18961/95 A AU18961/95 A AU 18961/95A AU 1896195 A AU1896195 A AU 1896195A AU 1896195 A AU1896195 A AU 1896195A
- Authority
- AU
- Australia
- Prior art keywords
- afgf
- growth factor
- fibroblast growth
- recombinant adenoviruses
- acidic fibroblast
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1825—Fibroblast growth factor [FGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/50—Fibroblast growth factors [FGF]
- C07K14/501—Fibroblast growth factors [FGF] acidic FGF [aFGF]
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9403190A FR2717495B1 (fr) | 1994-03-18 | 1994-03-18 | Virus recombinants, préparation et utilisation en thérapie génique. |
FR9403190 | 1994-03-18 | ||
PCT/FR1995/000249 WO1995025803A1 (fr) | 1994-03-18 | 1995-03-02 | ADENOVIRUS RECOMBINANTS CODANT POUR LE FACTEUR DE CROISSANCE DES FIBROBLASTES ACIDES (aFGF) |
Publications (1)
Publication Number | Publication Date |
---|---|
AU1896195A true AU1896195A (en) | 1995-10-09 |
Family
ID=9461189
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU18961/95A Abandoned AU1896195A (en) | 1994-03-18 | 1995-03-02 | Recombinant adenoviruses coding for acidic fibroblast growth factor (afgf) |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0750675A1 (fr) |
JP (1) | JPH09510357A (fr) |
AU (1) | AU1896195A (fr) |
CA (1) | CA2184409A1 (fr) |
FR (1) | FR2717495B1 (fr) |
IL (1) | IL112993A (fr) |
WO (1) | WO1995025803A1 (fr) |
ZA (1) | ZA952242B (fr) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2188575A1 (fr) | 1995-02-28 | 1996-09-06 | H. Kirk Hammond | Therapie angiogenique par transfert de genes |
US5792453A (en) * | 1995-02-28 | 1998-08-11 | The Regents Of The University Of California | Gene transfer-mediated angiogenesis therapy |
FR2792531B1 (fr) * | 1999-04-26 | 2003-01-31 | Aventis Pharma Sa | Utilisation d'adenovirus recombinant defectif comprenant un acide nucleique codant pour un facteur angiogenique pour le traitement de l'hypertension arterielle pulmonaire |
KR20020001846A (ko) * | 1999-04-26 | 2002-01-09 | 추후제출 | 폐순환승압을 치료하기 위한 맥관형성 인자를 암호화 하는핵산을 포함하는 재조합 결손 아데노바이러스의 용도 |
CA2430112C (fr) | 2000-11-27 | 2010-07-27 | Dnavec Research Inc. | Vecteur de paramyxovirus encodant le gene de l'angiogenese et son utilisation |
US20070134204A1 (en) * | 2005-12-09 | 2007-06-14 | Henrich Cheng | Method for treating nerve injury and vector construct for the same |
WO2009128474A1 (fr) | 2008-04-16 | 2009-10-22 | 財団法人化学及血清療法研究所 | Procédé de production d'une préparation de feuille bioabsorbable sur laquelle de la thrombine a été immobilisée |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2814529B2 (ja) * | 1989-03-16 | 1998-10-22 | 味の素株式会社 | 虚血性脳障害治療薬 |
NZ241021A (en) * | 1990-12-18 | 1993-12-23 | Amgen Inc | Analogues of acidic fibroblast growth factor and pharmaceutical |
AU3129793A (en) * | 1991-11-08 | 1993-06-07 | General Hospital Corporation, The | Methods for the treatment of neuronal damage associated with ischemia, hypoxia or neurodegeneration |
FR2688514A1 (fr) * | 1992-03-16 | 1993-09-17 | Centre Nat Rech Scient | Adenovirus recombinants defectifs exprimant des cytokines et medicaments antitumoraux les contenant. |
CA2145535C (fr) * | 1992-09-25 | 2007-07-17 | Axel Kahn | Vecteurs adenoviraux pour le transfert de genes etrangers dans des cellules du systeme nerveux central, notamment dans le cerveau |
FR2704234B1 (fr) * | 1993-04-22 | 1995-07-21 | Centre Nat Rech Scient | Virus recombinants, preparation et utilisation en therapie genique. |
-
1994
- 1994-03-18 FR FR9403190A patent/FR2717495B1/fr not_active Expired - Fee Related
-
1995
- 1995-03-02 CA CA002184409A patent/CA2184409A1/fr not_active Abandoned
- 1995-03-02 JP JP7524416A patent/JPH09510357A/ja active Pending
- 1995-03-02 AU AU18961/95A patent/AU1896195A/en not_active Abandoned
- 1995-03-02 EP EP95911370A patent/EP0750675A1/fr not_active Withdrawn
- 1995-03-02 WO PCT/FR1995/000249 patent/WO1995025803A1/fr not_active Application Discontinuation
- 1995-03-14 IL IL112993A patent/IL112993A/en not_active IP Right Cessation
- 1995-03-17 ZA ZA952242A patent/ZA952242B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
ZA952242B (en) | 1996-01-09 |
EP0750675A1 (fr) | 1997-01-02 |
FR2717495A1 (fr) | 1995-09-22 |
WO1995025803A1 (fr) | 1995-09-28 |
CA2184409A1 (fr) | 1995-09-28 |
FR2717495B1 (fr) | 1996-04-12 |
JPH09510357A (ja) | 1997-10-21 |
IL112993A (en) | 2006-09-05 |
IL112993A0 (en) | 1995-06-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2142595A (en) | Recombinant adenoviruses coding for basic fibroblast growth factors (bfgf) | |
IL116816A0 (en) | Recombinant defective adenoviruses | |
AU8147294A (en) | Recombinant viruses coding for thymidine kinase in gene therapy | |
AU5283793A (en) | Recombinant specific binding protein | |
AU3447097A (en) | Method for producing recombinant adenovirus | |
AU676586B2 (en) | Bone transporter | |
AU646320B2 (en) | Demand apnea control | |
AU2639095A (en) | Recombinant hk2 polypeptide | |
AU5524490A (en) | Demand oxygen system | |
AU2860497A (en) | Stabilized albumin-free recombinant factor VIII preparation having a low sugar content | |
AU4725793A (en) | Schwann cell mitogenic factor, its preparation and use | |
AU5901994A (en) | Tumor necrosis factor muteins | |
AU7042994A (en) | Recombinant (neu) differentiation factors | |
AU8147194A (en) | Recombinant adenoviruses for gene therapy in cancers | |
AU5109796A (en) | Export systems for recombinant proteins | |
AU1896195A (en) | Recombinant adenoviruses coding for acidic fibroblast growth factor (afgf) | |
AU4688499A (en) | Fibroblast growth factor receptor-5 | |
AUPN765396A0 (en) | Crypt system | |
AU3733497A (en) | Recombinant sef14 fimbrial protein from salmonella | |
AU2384195A (en) | Camber control sail system | |
AU2653195A (en) | Fibroblast growth factor 11 | |
AU2075899A (en) | Neurotrophic factor secretion promoters | |
AU1741000A (en) | Recombinant factor viii binding peptides | |
AU1896295A (en) | Recombinant adenoviruses coding for brain-derived neurotrophic factor (bdnf) | |
AU6309399A (en) | Peptide ligands for the human fibroblast growth factor (fgf) receptor |